Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Cancer × Interviews as Topic × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Prostatic Neoplasms 15 Neoplasms 14 Colorectal Neoplasms 11 Hematopoietic and Lymphatic System Neoplasm 8 Hematologic Neoplasms 8 Lung Neoplasms 7 Ovarian Neoplasms 4 Malignant Solid Neoplasm 4 Lymphoma 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Endometrial Neoplasms 3 Advanced Malignant Solid Neoplasm 3 Uterine Cervical Neoplasms 2 Obesity-Related Malignant Neoplasm 2 Mouth Neoplasms 2 Motor Activity 2 Leukemia 2 Hematopoietic and Lymphoid System Neoplasm 2 Head and Neck Carcinoma 2 Genital Neoplasms, Female 2 Genetic Predisposition to Disease 2 Depression 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Behavior 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1

Interventions

Nivolumab 5 Gemcitabine 2 zaleplon 1 temsirolimus 1 relatlimab 1 regorafenib 1 linrodostat 1 Vorinostat 1 Trastuzumab 1 Standard of Care 1 Sirolimus 1 Rehabilitation 1 Paclitaxel 1 Oxaliplatin 1 Ipilimumab 1 IFL protocol 1 Health Services Needs and Demand 1 Everolimus 1 Clinical Trials, Phase IV as Topic 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡